Skip Navigation LinksHome > March 2014 - Volume 21 - Issue 3 > Age at menopause, reproductive history, and venous thromboem...
Menopause:
doi: 10.1097/GME.0b013e31829752e0
Original Articles

Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: the Women’s Health Initiative hormone therapy clinical trials

Canonico, Marianne PhD1, 2; Plu-Bureau, Geneviève MD, PhD1,2,3; O’Sullivan, Mary Jo MD4; Stefanick, Marcia L. PhD5; Cochrane, Barbara PhD6; Scarabin, Pierre-Yves MD1,2; Manson, JoAnn E. MD, DrPH7

Editorial
Collapse Box

Abstract

Objective

This study aims to investigate venous thromboembolism (VTE) risk in relation to age at menopause, age at menarche, parity, bilateral oophorectomy, and time since menopause, as well as any interaction with randomized hormone therapy (HT) assignment, among postmenopausal women.

Methods

Using pooled data from the Women’s Health Initiative HT clinical trials including 27,035 postmenopausal women aged 50 to 79 years who had no history of VTE, we assessed the risk of VTE in relation to age at menopause, age at menarche, parity, bilateral oophorectomy, and time since menopause by Cox proportional hazards models. Linear trends, quadratic relationships, and interactions of reproductive life characteristics with HT on VTE risk were systematically tested.

Results

During follow-up, 426 women reported a first VTE, including 294 non–procedure-related events. No apparent interaction of reproductive life characteristics with HT assignment on VTE risk was detected, and there was not a significant association between VTE and age at menarche, age at menopause, parity, oophorectomy, or time since menopause. However, analyses restricted to non–procedure-related VTE showed a U-shaped relationship between age at menopause and thrombotic risk that persisted after multivariable analysis (P < 0.01). Compared with women aged 40 to 49 years at menopause, those who had early menopause (age <40 y) or late menopause (age >55 y) had a significantly increased VTE risk (hazard ratio [95% CI]: 1.8 [1.2-2.7] and 1.5 [1.0-2.4], respectively).

Conclusions

Reproductive life characteristics have little association with VTE and do not seem to influence the effect of HT on thrombotic risk among postmenopausal women. Nevertheless, early and late onset of menopause might be newly identified risk factors for non–procedure-related VTE.

© 2014 by The North American Menopause Society

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.